A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)

~20 mi. (Bilbao, Spain, +356 more cities)

Hospital Universitario de Basurto

HER2 Positive

Invasive Breast Carcinoma

fam-trastuzumab deruxtecan

targeted therapy

A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy

~20 mi. (Bilbao, Spain, +260 more cities)

Hospital de Basurto; Servicio de Oncologia

ERBB2 Amplification, +1 more biomarker

Invasive Breast Carcinoma

ado-trastuzumab emtansine, +1 more drug

immunotherapy, +1 more type

A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

~67 mi. (Santander, Spain, +144 more cities)

Hospital Universitario Marques de Valdecilla ( Site 1501)

Clear Cell Renal Cell Carcinoma

belzutifan, +3 more drugs

immunotherapy, +1 more type

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)

~67 mi. (Santander, Spain, +131 more cities)

Hospital Universitario Marques de Valdecilla ( Site 1902)

HER2 Negative

Adenocarcinoma of the Gastroesophageal Junction, +2 more conditions

CAPOX regimen, +3 more drugs

chemotherapy, +2 more types

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)

~67 mi. (Santander, Spain, +45 more cities)

Hospital Universitario Marques de Valdecilla ( Site 1602)

Esophageal Squamous Cell Carcinoma

cisplatin, +5 more drugs

chemotherapy, +2 more types

A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors

~67 mi. (Santander, Spain, +118 more cities)

Hospital Universitario "Marqués de Valdecilla"

NTRK1 Fusion, +2 more biomarkers

Biliary Tract Carcinoma, +12 more conditions

larotrectinib

targeted therapy

A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

~67 mi. (Santander, Spain, +52 more cities)

Hospital Universitario Marques de Valdecilla; Servicio de Hematologia

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

gemcitabine, +4 more drugs

chemotherapy, +1 more type

Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma

~67 mi. (Santander, Spain, +42 more cities)

University Hospital Marqués de Valdecilla

Esophageal Squamous Cell Carcinoma

cisplatin/fluorouracil regimen, +2 more drugs

chemotherapy, +1 more type

Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma

~67 mi. (Santander, Spain, +54 more cities)

Hospital Unversitario Marques de Valdecilla /ID# 229354

Multiple Myeloma

carfilzomib, +4 more drugs

chemotherapy, +3 more types

Study Evaluating Efficacy and Safety of Capmatinib in Combination With Osimertinib in Adult Subjects With Non-small Cell Lung Cancers as Second Line Therapy

~67 mi. (Santander, Spain, +9 more cities)

Novartis Investigative Site

EGFR A763_Y764insFQEA, +7 more biomarkers

Non-Small Cell Lung Carcinoma

capmatinib, +1 more drug

targeted therapy

Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy

~67 mi. (Santander, Spain, +55 more cities)

Hospital Universitario Marqués de Valdecilla (Adults and Pediatrics)

Post-Transplant Lymphoproliferative Disorder

tabelecleucel

cellular therapy, +1 more type

Study of ASTX727 vs IV Decitabine in MDS, CMML, and AML

~67 mi. (Santander, Spain, +74 more cities)

Hospital U. Marqués de Valdecilla

Acute Myeloid Leukemia, +4 more conditions

decitabine, +1 more drug

chemotherapy